SCHEMBL5058630

SCHEMBL5058630

COc1cc2c(c(-c3ccc(F)c(Cl)c3)c1)OC(C)C2

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 2/20 0.38
HTR2A P28223 1/20 0.38
PTGS2 P35354 6/20 0.37
BRD4 O60885 2/20 0.36
CREBBP Q92793 1/20 0.36
MAPT P10636 2/20 0.35
PTGS1 P23219 3/20 0.34
FYN P06241 1/20 0.34
PARP1 P09874 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
EGFR P00533 1/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PGR P06401 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058627 0.87 PTGS2 (0.36) GRM2HTR2APTGS2BRD4CREBBP
SCHEMBL4597199 0.86 GRM2 (0.42) GRM2HTR2APTGS2BRD4CREBBP
SCHEMBL4225394 0.84 AQP1 (0.51) GRM2HTR2APTGS2PTGS1FYN
SCHEMBL4220627 0.83 AQP1 (0.43) GRM2HTR2APTGS2PTGS1FYN
SCHEMBL4220623 0.82 AQP1 (0.54) GRM2HTR2APTGS2MAPTALDH1A1
SCHEMBL4596127 0.81 GRM2 (0.38) GRM2HTR2APTGS2BRD4CREBBP
SCHEMBL4758945 0.79 AQP1 (0.46) MAPTALDH1A1KDM4ETSHRHSD17B10
SCHEMBL4595609 0.79 S1PR4 (0.38) BRD4CREBBPMAPTALDH1A1KDM4E
SCHEMBL4713098 0.79 PARP1 (0.39) PARP1ALDH1A1KDM4ETSHRHSD17B10
SCHEMBL4968877 0.78 AQP1 (0.42) PTGS2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871354-A1 TREATMENT OF PAIN Wyeth (US) 2008-01-02 EP claimed
JP-2007509174-A 2007-04-12 JP claimed
WO-2006116171-A1 TREATMENT OF PAIN WYETH (US) 2006-11-02 WO claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP claimed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP disclosed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO disclosed